Abstract
Statins, inhibitors of HMG-CoA reductase, have been used for decrease morbidity and mortality not only in cardiovascular disease, but also in important infectious disease like pneumonia and sepsis recently through the anti-inflammatory pleiotropic effects. But it is stil not clear that how statins accomplish these effects. They affect the complex inflammatory cascade mostly regarded as not related to lowering LDL cholesterol, but changing in NO balance, leucocyte–endothelium interactions, and inflammatory cell signaling or gene expression, affecting mononuclear-cell activity, coagulation, fibrinolysis and oxidative stress. Several promising publications demonstrated that statins could get in role in sepsis besides that we expected. In this review, we evaluate the mechanism of action of statins on inflammatory cascade of sepsis and their effects on clinical outcomes.
Keywords
Additional Information
Publisher’s Note
Bayrakol MP remains neutral with regard to jurisdictional and institutional claims.
Rights and Permissions
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/
About This Article
How to Cite This Article
Zekeriya Arslan, Mustafa Aparcı, Murat Ünlü. Statin as an anti-ınflammatory agent in sepsis. J Clin Anal Med 2014;5(4):347-352. doi:10.4328/JCAM.1535
Publication History
- Received:
- 12.01.2013
- Accepted:
- 01.02.2013
- Published Online:
- 01.07.2014
- Printed:
- 01.07.2014